Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study
Journal of Internal Medicine · 2025-12 · 298 (6) · 604-616
DOI: 10.1111/joim.70012 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Internal Medicine, online erschienen am 23.08.2025. Verfasst von Minjeong Jeon und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon, South Korea. Hauptthemen laut MEDLINE: Colchicine, Gout, Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Food and Drug Safety, National Research Foundation of Korea.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) and gout are associated with an increased risk of cardiovascular events. Despite the approval for the secondary prevention of cardiovascular diseases by the United States Food and Drug Administration in 2023, evidence regarding the effectiveness of colchicine among T2DM population remains limited.
Objectives
We aimed to evaluate the association between the use of colchicine and the risk of major adverse cardiovascular events (MACE) among patients with gout and T2DM.
Methods
We conducted a nationwide, population‐based cohort study with active comparator, new‐user design using nationwide claims data of South Korea (2010–2022). Patients with T2DM and gout who initiated colchicine or non‐steroidal anti‐inflammatory drugs (NSAIDs) from 2011 to 2022 were included. The primary outcome was MACE (myocardial infarction, ischemic stroke, and cardiovascular death). Secondary outcomes were each individual components of primary outcome and hospitalization due to heart failure. As‐treated approach with 30‐day grace period was applied.
Results
Before propensity score (PS) matching, 13,019 colchicine users and 111,594 NSAIDs users were included in the study cohort (mean age, 65.5 vs. 62.9; 35.0% vs. 29.8% female). After 1:2 PS matching, 12,908 colchicine users and 25,816 NSAIDs users remained (mean age, 65.7 vs. 65.7 years; 35.2% vs. 35.1% female). The PS‐matched hazard ratio for MACE was 0.94 (95% confidence interval 0.65–1.36), and all secondary outcomes also resulted in null findings.
Conclusions
Use of colchicine does not significantly reduce the risk of MACE compared with NSAIDs in a real‐world population with T2DM and gout in South Korea between 2011 and 2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
- Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Department of Pharmacology, Ajou University School of Medicine, Suwon, South Korea.
- Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
ORCID-Profile: Yongtai Cho, Yoosoo Chang, Ju-Young Shin
Förderung
- Ministry of Food and Drug Safety
- National Research Foundation of Korea
Zitieren
APA
Jeon, M., Cho, Y., Bea, S., You, W., Cho, S. K., Ryu, S., Chang, Y., & Shin, J. Y. (2025). Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study. Journal of Internal Medicine, 298(6), 604-616. https://doi.org/10.1111/joim.70012
Vancouver
Jeon M, Cho Y, Bea S, You W, Cho SK, Ryu S, et al. Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study. Journal of Internal Medicine. 2025;298(6):604-616. doi:10.1111/joim.70012
BibTeX
@article{Jeon2025,
author = {Jeon, Minjeong and Cho, Yongtai and Bea, Sungho and You, Wonkyoung and Cho, Sung Kweon and Ryu, Seungho and Chang, Yoosoo and Shin, Ju-Young},
title = {Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study},
journal = {Journal of Internal Medicine},
year = {2025},
volume = {298},
number = {6},
pages = {604--616},
doi = {10.1111/joim.70012}
}
EUVIMED